Dr. Durando is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3838 N Campbell Ave
Tucson, AZ 85719Phone+1 617-818-3441
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2017 - 2021
Penn MedicinePost-Doctoral Fellowship, 2018 - 2019- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2016 - 2017
Emory University School of MedicineInternship, Internal Medicine, 2015 - 2016
University of North Carolina at Chapel Hill School of MedicineClass of 2015
Certifications & Licensure
ID State Medical License 2024 - 2026
NM State Medical License 2022 - 2026
UT State Medical License 2021 - 2026
AZ State Medical License 2021 - 2025
PA State Medical License 2019 - 2024- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma.Michael Durando, Ajay K Gopal, Joseph Tuscano, Daniel Persky
The Oncologist. 2024-04-04 - 5 citationsFour-Year Disease-Free Remission in a Patient With POLE Mutation-Associated Colorectal Cancer Treated Using Anti-PD-1 Therapy.Michael L Durando, Sanjay V Menghani, Jessica L Baumann, Danny G Robles, Tovah A Day
Journal of the National Comprehensive Cancer Network. 2022-03-01 - 180 citationsCXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and BeyondMarcelo G. Kazanietz, Michael Durando, Mariana Cooke
Frontiers in Endocrinology. 2019-07-12
Grant Support
- Regulatory Signaling in Repair of Environmentally Induced DNA DamageNIEHS2010–2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
